Kreon (Pancreas Powder)

• Kreon is used in the management of disorders characterized by insufficient pancreatic enzyme production.
• Exocrine pancreatic insufficiency: improves digestion of fats, proteins and carbohydrates, helping to alleviate malabsorption symptoms.
• Cystic fibrosis: provides the necessary pancreatic enzymes to support nutrient absorption in patients with pancreatic dysfunction.
• Chronic pancreatitis: supplements deficient endogenous enzymes, aiding in the breakdown of dietary nutrients and reducing steatorrhea.

• Kreon contains a mixture of pancreatic lipases, proteases and amylases that are released in the duodenum. These enzymes hydrolyze dietary triglycerides, proteins and starches, respectively, compensating for the reduced endogenous secretion seen in exocrine pancreatic insufficiency. By restoring enzymatic activity in the gastrointestinal tract, the product facilitates the conversion of macronutrients into absorbable molecules, thereby improving nutritional status. The enzymes are enteric‑coated to protect them from gastric acid and ensure release at optimal pH.

Like other pancreatic enzyme preparations, Kreon may be associated with a range of adverse reactions.

Common Side Effects

• Abdominal discomfort
• Flatulence
• Diarrhea
• Nausea
• Oily or fatty stools

Serious or Rare Side Effects

• Allergic reactions including rash, itching or anaphylaxis
• Severe abdominal pain or pancreatitis
• Intestinal obstruction or blockage
• Respiratory distress due to hypersensitivity

• When prescribing Kreon, clinicians should consider several precautionary measures to ensure safe and effective use.
• Dose individualisation: adjust the enzyme dose based on the patient’s clinical response and nutritional status.
• Monitoring nutritional status: regularly assess weight, fat‑soluble vitamin levels and stool fat content.
• Acid suppression therapy: concomitant use of proton pump inhibitors may be required to optimise enzyme activity.
• Allergy assessment: avoid use in patients with known hypersensitivity to porcine‑derived pancreatic extracts.
• Renal or hepatic impairment: use caution and consider dose modification in severe organ dysfunction.
• Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Kreon can interact with certain medicines that affect gastrointestinal pH or bind to enzymes, altering its efficacy.

Major Interactions (Avoid)

• Bile acid sequestrants (e.g., cholestyramine, colestipol): bind pancreatic enzymes and markedly reduce their activity.
• Antacids containing aluminum or magnesium: may interfere with enzyme absorption when taken simultaneously.
• High‑dose proton pump inhibitors: may require dose adjustment of Kreon to maintain therapeutic effect.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: possible reduced absorption of estrogen components; monitor contraceptive efficacy.
• Warfarin: monitor INR as changes in vitamin K absorption may affect anticoagulation.
• Diabetes medications: altered carbohydrate digestion may affect glycemic control; adjust doses as needed.
• Antibiotics such as tetracycline: may chelate with enzymes; observe for reduced efficacy.